Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate‐Treated Patients in a Real‐World Setting

Bone mineral density (BMD) is an established measure used to diagnose patients with osteoporosis. In clinical trials, change in BMD has been shown to provide a reliable estimate of fracture risk reduction, and achieved BMD T‐score has been shown to reflect the near‐term risk of fracture. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Banefelt, Jonas, Timoshanko, Jen, Söreskog, Emma, Ortsäter, Gustaf, Moayyeri, Alireza, Åkesson, Kristina E., Spångéus, Anna, Libanati, Cesar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298264/
https://www.ncbi.nlm.nih.gov/pubmed/34585781
http://dx.doi.org/10.1002/jbmr.4448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298264/
https://www.ncbi.nlm.nih.gov/pubmed/34585781
http://dx.doi.org/10.1002/jbmr.4448

Ejemplares similares